Know Cancer

forgot password

Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology

18 Years
Open (Enrolling)
Ovarian Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Neoplasms of the Female Genitalia, Lung Neoplasms, Endocrine Gland Neoplasms

Thank you

Trial Information

Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology

Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to
translational research. The relevance of "translational oncology" will only increase in the
future -"From bench to bedside" - the swift implementation of new science research results
in clinical studies in order to expedite progress in clinical cancer therapy for the benefit
of the patient.

Its almost a matter of course in the medical science today to collect biological samples
together with clinical information thereby creating the foundation for future excellent
fundamental research.

The aim of this tumor bank is to consist of biological samples (together with a blood bank -
see NCT01763125) and isolates of tumor patients and healthy people as controls. The
biological samples, the clinical date together with prospective experimental date constitute
the entity of the tumor bank. The content of the tumor bank can provide essential material
for current and future research (e.g. analyses of prognostic or predictive tumor markers;
genetically analysis (polymorphism, mutation, hypermethylation; verification and
characterisation of disseminated tumor cells).

Inclusion Criteria:

- Male/Female

- Age 18 to 90 years max.

- Just one current known malignant disease or just one current inflammatory disease

Exclusion Criteria:

- Inflammatory disease and malignant disease

- multiple malignancies

- multiple diseases

- underage

Type of Study:


Study Design:

Observational Model: Case Control

Outcome Measure:

Establishment of blood/tissue bank consisting of oncological samples from cancer patients and benign and healthy controls.

Outcome Time Frame:

14 years

Safety Issue:


Principal Investigator

Robert Zeillinger, Prof.Dr.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Medical University of Vienna, Dptm. of Obstetrics & Gynaecology


Austria: Ethikkommission

Study ID:

EK 260/2003



Start Date:

September 2003

Completion Date:

January 2017

Related Keywords:

  • Ovarian Neoplasms
  • Breast Neoplasms
  • Colorectal Neoplasms
  • Neoplasms of the Female Genitalia
  • Lung Neoplasms
  • Endocrine Gland Neoplasms
  • Breast cancer
  • Ovarian cancer
  • Endometrium carcinoma
  • Cervix carcinoma,
  • Mamma carcinoma,
  • Prostata carcinoma
  • Colon carcinoma
  • Rectal carcinoma
  • Bronchus carcinoma
  • NSCLC (non small cell lung cancer) & SCLC (small cell lung cancer)
  • Prostate carcinoma
  • Breast Neoplasms
  • Neoplasms
  • Colorectal Neoplasms
  • Endocrine Gland Neoplasms
  • Lung Neoplasms
  • Ovarian Neoplasms